
    
      Mucus hypersecretion plays an essential role in bronchiectasis. It has been deduced that
      reducing the production of mucus or improving the clearance of sputum in the airway is the
      key to break down this "vicious cycle" and enhance the therapeutic efficacy for
      bronchiectasis.

      The investgators aimed to assess whether the long-term use of oral An'Ningpai Enteric Soft
      Capsules (300 mg, three times daily) might reduce the rate of exacerbations and improve the
      quality of life in patients with bronchiectasis.
    
  